Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine

Clinical trial NCT04711005 · COMPLETED

Trial details

NCT number: NCT04711005
Sponsor: National Institute of Mental Health (NIMH)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2021-01-11
Primary completion: 2023-04-30
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.